Skip to main content
SpringerLink
Log in

Vasodilatatoren und positiv-inotrope Pharmaka

  • Chapter
Intensivmedizin

  • 39 Accesses

Zusammenfassung

Zum Verständnis der Pharmakoptherapie bei Herzinsuffizienz sei an zwei hämodynamische Besonderheiten des insuffizienten linken Ventrikels erinnert:

  • Die Ventrikelfunktionskurve verläuft abnorm: sie ist abgeflacht, erreicht ihr Maximum bei höheren Füllungsdrücken und fällt bei weiterer Steigerung des Füllungsdruckes möglicherweise wieder ab.

  • Die Förderleistung des Herzens hängt in starkem Maße vom peripheren Gefäßwiderstand ab.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bayley S, Valentine H, Bennett ED (1984) The haemodynamic responses to incremental doses of intravenous nitroglycerin in left ventricular failure. Intensive Care Med 10: 139–145

    Article  PubMed  CAS  Google Scholar 

  2. Biddle TL, Benotti JR, Creager A et al. (1987) Comparison of intravenous milgrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy. Am J Cardiol 59: 1345–1350

    Article  PubMed  CAS  Google Scholar 

  3. Boldt J, Kling D, Schuhmann E et al. (1989) Hämodynamische Effekte des neuen Phosphodiesterasehemmers Enoximone bei kardiochirurgischen Patienten. Anaesthesist 38: 238–244

    PubMed  CAS  Google Scholar 

  4. Chatterjee K (1973) Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction. Circulation 48: 1183

    Article  PubMed  CAS  Google Scholar 

  5. Crexells C, Chatterjee K, Forrester JS et al. (1973) Optimal level of filling pressure in the left side of the heart in acute myocardial infarction. N Engl J Med 289: 1263–1266

    Article  PubMed  CAS  Google Scholar 

  6. Cyran J, Kühnl C, Zähringer J et al. (1978) Die Änderung der Hämodynamik des Herzens unter dem kombinierten Einfluß von Nitroglyzerin und Dopamin bei hochgradiger Linksherzinsuffizienz. Z Kardiol 67: 759–765

    PubMed  CAS  Google Scholar 

  7. Cyran J, Bolte HD (1981) Parenterale Kombinationstherapie mit Katecholaminen und Vasodilatantien bei koronarer Herzkrankheit. In: Bolte HD (Hrsg) Katecholamine und Vasodilatantien bei Herzinsuffizienz. Springer, Berlin Heidelberg New York, S 55–63

    Chapter  Google Scholar 

  8. Desjars P, Pinaud M, Bugnon D, Tasseau F (1989) Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 17: 426–429

    Article  PubMed  CAS  Google Scholar 

  9. Fowler MB, Alderman EL, Oesterle SN et al. (1984) Dobutamine and dopamine after cardiac surgery: greater aufmentation of myocardial blood flow with dobutamine. Circulation 70: I-103-I-111

    Google Scholar 

  10. Franciosa JA, Dunkman WB, Wilen M. Silverstein SR (1983) „Optimal“ left ventricular filling pressure during nitroprusside infusion for congestive heart failure. Am J Med 74: 457–464

    Article  PubMed  CAS  Google Scholar 

  11. Francis GS, Sharma B, Hodges M (1982) Comparative hemodynamic effects of dopamine and dobutamine in patients with acute cardiogenic circulatory collapse. Am Heart J 103: 995–1000

    Article  PubMed  CAS  Google Scholar 

  12. Gage J, Rutman H, Lucido D (1986) Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performance in patients with severe heart failure. Circulation 74: 367–371

    Article  PubMed  CAS  Google Scholar 

  13. Goldstein RA, Passamani ER, Roberts R (1980) A comparison of digoxin and dobutamine in patients with acute infarction and cardiac failure. N Engl J Med 303: 846–850

    Article  PubMed  CAS  Google Scholar 

  14. Heuer H, Frenking B, Müller US, Gülker H (1987) Wirkung von Amrinon bei akuter schwerer Herzinsuffizienz. Intensivmed 24: 133–137 31.

    Google Scholar 

  15. Hoffmann P, Schockenhoff (1985) Amrinon beim katecholaminrefraktären Herzversagen im septischen Schock. Anaesthesist 34: 663–669

    PubMed  CAS  Google Scholar 

  16. Installé E, Gonzalez M, Jacquemart JL et al. (1987) Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure. Am J Cardiol 60: 46C - 52C

    Article  PubMed  Google Scholar 

  17. Keung ECH, Siskind SJ, Sonneblick EH et al. (1981) Dobutamine therapy in acute myocardial infarction. J Amer med Ass 245: 144–146

    Article  CAS  Google Scholar 

  18. Konstam MA, Cohen SR, Weiland DS et al. (1986) Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure. Am J Cardiol 57: 242–248

    Article  PubMed  CAS  Google Scholar 

  19. Leier CV, Bambach D, Thompson MJ et al. (1981) Central and regional hemodynamic effects of intravenous isosorbide dinitrate, nitroglycerin and nitroprusside in patients with congestive heart failure. Am J Cardiol 48: 1115–1123

    Article  PubMed  CAS  Google Scholar 

  20. Leier CV. Binkley PF, Carpenter J et al. (1988) Cardiovascular pharmacology of dopexamine in low output congestive heart failure. Am J Cardiol 62: 94–99

    Article  PubMed  CAS  Google Scholar 

  21. Loeb HS, Bredakis J, Gunnar RMN: Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure. Circulation 65: 375–381

    Google Scholar 

  22. Mager G, Klocke RK, Kux A et al. (1990) Therapie des kardiogenen Schocks and der schwersten Herzinsuffizienz mit dem Phosphodiesterasehemmer Milrinon. Intensivmed 27

    Google Scholar 

  23. Martyn J, Wilson RS, Burke JF (1986) Right ventricular function and pulmonary hemodynamics during dopamine infusion in burned patients. Chest 89: 357–360

    Article  PubMed  CAS  Google Scholar 

  24. Meadows D, Edwards JD, Wilkins RG, Nightingale P (1988) Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 16: 663–666

    Article  PubMed  CAS  Google Scholar 

  25. Müller HS (1979) Myokardinfarkt–Kardiogener Schock. Intensivmed 16: 115–121

    Google Scholar 

  26. Nelson GLC, Silke B. Ahuja RC, Hussain M (1983) Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart-failure following myocardial infarction. Lancet 1: 730–733

    Article  PubMed  CAS  Google Scholar 

  27. Nienaber CA, Spielmann RP, Aschenberg W et al. (1987) Comparison of the acute hemodynamic response to intravenous nisoldipine (Bay K 5552) and intravenous nifedipine for left ventricular dysfunction secondary to myocardial infarction. Am J Cardiol 60: 836–841

    Article  PubMed  CAS  Google Scholar 

  28. Rennotte MT, Reynaert M, Clerbaux T et al. (1989) Effects of two inotropic drugs, dopamine and dobutamine, on pulmonary gas exchange in artificially ventilated patients. Intensive Care Med 15: 160–165

    Article  PubMed  CAS  Google Scholar 

  29. Richard C, Ricome JL, Rimalho A et al. (1983) Combined hemodynamic effects of dopamine and dobutamine in cardiogenic shock. Circulation 67: 620–626

    Article  PubMed  CAS  Google Scholar 

  30. Schuster HP (1985) Behandlung von Herzinsuffizienz and Schock. Verh Dtsch Ges Inn Med 91: 212–225

    PubMed  CAS  Google Scholar 

  31. Svenson G, Strandberg LE, Lindvall B. Erhardt L (1988) Haemodynamic response to dopexamine hydrochloride in postinfarction heart failure: lack of tolerance after continuous infusion. Br Heart J 60: 489–496

    Article  PubMed  CAS  Google Scholar 

  32. Vincent JL, Carlier E, Berr’e J et al. (1988) Am J Cardiol 62: 419–423

    Article  PubMed  CAS  Google Scholar 

  33. Worthley LIG, Tyler P, Maron JL (1985) A comparison of dopamine, dobutamine and isoproterenol in the treatment of shock. Intensive Care Med 11: 13–19

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. H. P. Schuster
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Univ.-Klinik für Anästhesie und Allgemeine Intensivmedizin, Univ. Innsbruck, Anichstr. 35, A-6020, Innsbruck, Österreich

    Herbert Benzer

  2. Zentrum Anästhesiologie, Rettungs- und Intensivmedizin, Universität Göttingen, Robert-Koch-Str. 40, D-3400, Göttingen, Deutschland

    H. Burchardi

  3. Klinik für Anästhesiologie und Intensivmedizin, Universitätskliniken des Saarlands, D-6650, Homburg/Saar, Deutschland

    Reinhard Larsen

  4. Div. des Soins Intensifs Chirurgicaux, Département d’Anesthésiologie, Hôpital Cantonal Universitaire, CH-1211, Genève 14, Schweiz

    Peter M. Suter

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schuster, H.P. (1993). Vasodilatatoren und positiv-inotrope Pharmaka. In: Benzer, H., Burchardi, H., Larsen, R., Suter, P.M. (eds) Intensivmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97183-9_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-97183-9_32

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-97184-6

  • Online ISBN: 978-3-642-97183-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation